Elevance Health Inc. (ELV) Quick Ratio (Acid-Test): 1.24
Is Elevance Health Inc.’s quick ratio (acid-test) high or low?
Elevance Health Inc.'s quick ratio (acid-test) of 1.24 is 16% above its 5-year average of 1.07, near the high end of its 5-year range (0.94–1.24).
As of Sunday, June 14, 2026. 5.98% above its 12-month average of 1.17.
ELV Quick Ratio (Acid-Test) Chart
ELV Average Quick Ratio (Acid-Test) Chart
ELV Current vs Average Quick Ratio (Acid-Test) Chart
ELV Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
1.24
QUICK RATIO (ACID-TEST) AVG TTM
1.17
QUICK RATIO (ACID-TEST) AVG 3Y
1.08
QUICK RATIO (ACID-TEST) AVG 5Y
1.07
QUICK RATIO (ACID-TEST) AVG 10Y
1.04
QUICK RATIO (ACID-TEST) AVG 15Y
0.98
QUICK RATIO (ACID-TEST) AVG 20Y
1.01
CURRENT VS TTM AVG
+5.98%
CURRENT VS 3Y AVG
+14.29%
CURRENT VS 5Y AVG
+15.89%
CURRENT VS 10Y AVG
+18.71%
CURRENT VS 15Y AVG
+26.29%
CURRENT VS 20Y AVG
+22.43%
ELV Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elevance Health Inc. (ELV) | $87.75B | 1.24 | 1.17 | 1.08 | 1.07 |
| Cigna Corporation (CI)vs › | $78.83B | 0.72 | 0.72 | 0.68 | 0.69 |
| Medtronic plc (MDT)vs › | $102.97B | 0.00 | 1.48 | 1.57 | 1.68 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.06B | 3.39 | 3.67 | 4.14 | 3.76 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $112.92B | 2.46 | 2.41 | 3.31 | 3.62 |
| Bristol-Myers Squibb Company (BMY)vs › | $116.66B | 1.14 | 1.15 | 1.19 | 1.27 |
| Cencora, Inc. (COR)vs › | $54.80B | 0.55 | 0.54 | 0.53 | 0.55 |
| Becton, Dickinson and Company (BDX)vs › | $52.98B | 0.64 | 0.69 | 0.70 | 0.80 |
| Danaher Corporation (DHR)vs › | $127.47B | 1.51 | 1.28 | 1.37 | 1.36 |
| Humana Inc. (HUM)vs › | $45.53B | 0.72 | 0.58 | 0.57 | 0.58 |
Liquidity Comparison
Quick Ratio
1.24
Excludes inventory
Current Ratio
1.24
Includes inventory
Elevance Health Inc. Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Elevance Health Inc. Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The quick ratio (acid-test) for ELV stock is 1.24.
- Is Elevance Health Inc.'s quick ratio (acid-test) high or low?
- Elevance Health Inc.'s quick ratio (acid-test) of 1.24 is 16% above its 5-year average of 1.07, near the high end of its 5-year range (0.94–1.24).
- What is the TTM average quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The TTM average quick ratio (acid-test) for ELV stock is 1.17.
- What is the 3Y average quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The 3Y average quick ratio (acid-test) for ELV stock is 1.08.
- What is the 5Y average quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The 5Y average quick ratio (acid-test) for ELV stock is 1.07.
- What is the 10Y average quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The 10Y average quick ratio (acid-test) for ELV stock is 1.04.
- What is the 15Y average quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The 15Y average quick ratio (acid-test) for ELV stock is 0.98.
- What is the 20Y average quick ratio (acid-test) for Elevance Health Inc. (ELV)?
- The 20Y average quick ratio (acid-test) for ELV stock is 1.01.
Elevance Health Inc. Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 1.24 |
| 2024-12-31 | 1.10 |
| 2023-12-31 | 0.97 |
| 2022-12-31 | 1.03 |
| 2021-12-31 | 0.94 |
| 2020-12-31 | 1.14 |
| 2019-12-31 | 1.11 |
| 2018-12-31 | 1.13 |
| 2017-12-31 | 0.93 |
| 2016-12-31 | 1.07 |
| 2015-12-31 | 0.83 |
| 2014-12-31 | 0.88 |
| 2013-12-31 | 0.79 |
| 2012-12-31 | 0.88 |
| 2011-12-31 | 0.82 |
| 2010-12-31 | 0.85 |
| 2009-12-31 | 1.23 |
| 2008-12-31 | 0.63 |
| 2007-12-31 | 0.81 |
| 2006-12-31 | 0.75 |
| 2005-12-31 | 2.14 |
| 2004-12-31 | 0.60 |
Related Metrics
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux